Biomarker for Prognosing Metastasis of Melanoma Kit Comprising the Same and Screening Method for Compound Preventing Metastasis of Melanoma

摘要

The present invention relates to a biomarker composition for predicting melanoma metastasis prognosis, comprising at least one selected from aminomalonic acid or phosphatidylinositol as an active ingredient, a composition for predicting melanoma metastasis prognosis using the same, kit, prognosis The present invention relates to a method for providing information necessary for prediction and a screening method of a compound inhibiting melanoma metastasis, which comprises not only a single biomarker for predicting metastatic prognosis of a melanoma which is difficult to predict aminomalonic acid, phosphatidylinositol, In addition, by using pyroglutamic acid, ornithine and cysteine as biomarkers in addition, the metastatic prognosis of melanomas can be predicted more effectively and accurately.